breast ductal carcinoma in situ
Showing 1 - 15 of 15
Breast Atypical Hyperplasia, Breast Carcinoma, Breast Ductal Carcinoma In Situ Trial in United States (Acolbifene Hydrochloride,
Not yet recruiting
- Breast Atypical Hyperplasia
- +3 more
- Acolbifene Hydrochloride
- +4 more
-
Duarte, California
- +3 more
Jul 11, 2023
Breast Ductal Carcinoma In Situ Trial in Worldwide (other, biological, radiation)
Active, not recruiting
- Breast Ductal Carcinoma In Situ
- Laboratory Biomarker Analysis
- +2 more
-
Anniston, Alabama
- +1267 more
Jan 28, 2023
Breast Ductal Carcinoma In Situ, Invasive Breast Carcinoma, Multicentric Breast Carcinoma Trial in Worldwide (Anastrozole,
Active, not recruiting
- Breast Ductal Carcinoma In Situ
- +4 more
- Anastrozole
- +6 more
-
Anniston, Alabama
- +1582 more
Jan 28, 2023
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial
Suspended
- Anatomic Stage I Breast Cancer AJCC v8
- +23 more
- Short-Term Fasting
- Chemotherapy
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Jan 23, 2023
Breast Atypical Ductal Hyperplasia, Breast Atypical Lobular Hyperplasia, Breast Ductal Carcinoma In Situ Trial in Houston
Completed
- Breast Atypical Ductal Hyperplasia
- +4 more
- Bexarotene
- Questionnaire Administration
-
Houston, TexasM D Anderson Cancer Center
Dec 13, 2022
Anatomic Stage 0 Breast Cancer AJCC v8, Bilateral Breast Carcinoma, Breast Ductal Carcinoma In Situ Trial in Chicago
Recruiting
- Anatomic Stage 0 Breast Cancer AJCC v8
- +5 more
- Intraoperative Imaging
- Lumpectomy
-
Chicago, Illinois
- +3 more
Nov 30, 2022
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Breast Ductal Carcinoma In Situ Trial in
Not yet recruiting
- Anatomic Stage I Breast Cancer AJCC v8
- +3 more
- Biospecimen Collection
- +4 more
-
Houston, Texas
- +2 more
Aug 17, 2022
Breast Ductal Carcinoma In Situ, Invasive Breast Carcinoma Trial in Duarte (Agent Affecting Integumentary System,
Recruiting
- Breast Ductal Carcinoma In Situ
- Invasive Breast Carcinoma
- Agent Affecting Integumentary System
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jun 30, 2022
Breast Ductal Carcinoma In Situ, Breast Lobular Carcinoma In Situ, Stage 0 Breast Cancer AJCC v6 and v7 Trial in Los Angeles,
Active, not recruiting
- Breast Ductal Carcinoma In Situ
- +12 more
- Endoxifen Hydrochloride
- +2 more
-
Los Angeles, California
- +2 more
Mar 8, 2022
BRCA1/2-Associated Hereditary Breast and Ovarian Cancer Syndrome, Breast Ductal Carcinoma In Situ, Hematopoietic and Lymphoid
Recruiting
- BRCA1/2-Associated Hereditary Breast and Ovarian Cancer Syndrome
- +5 more
- Biospecimen Collection
- +3 more
-
Portland, Oregon
- +1 more
Feb 9, 2022
Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 Trial in
Recruiting
- Anatomic Stage 0 Breast Cancer AJCC v8
- +23 more
- Behavioral Intervention
- +2 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Dec 16, 2021
Breast Ductal Carcinoma In Situ Trial in Jacksonville, Rochester (Granulocyte-Macrophage Colony-Stimulating Factor,
Recruiting
- Breast Ductal Carcinoma In Situ
- Granulocyte-Macrophage Colony-Stimulating Factor
- +2 more
-
Jacksonville, Florida
- +1 more
Dec 10, 2021
Breast Carcinoma, Breast Ductal Carcinoma In Situ, Breast Lobular Carcinoma In Situ Trial in Columbus (EMBr Wave, Questionnaire
Recruiting
- Breast Carcinoma
- +3 more
- EMBr Wave
- Questionnaire Administration
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Oct 20, 2021
Breast Ductal Carcinoma In Situ Trial in United States (other, drug, biological, procedure)
Active, not recruiting
- Breast Ductal Carcinoma In Situ
- Laboratory Biomarker Analysis
- +3 more
-
Boston, Massachusetts
- +3 more
Jun 30, 2021
Breast Ductal Carcinoma in Situ Trial in Taipei (Low-dose tamoxifen, Whole breast radiotherapy)
Recruiting
- Breast Ductal Carcinoma in Situ
- Low-dose tamoxifen
- Whole breast radiotherapy
-
Taipei, TaiwanNational Taiwan University Hospital
Aug 4, 2019